Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Leora Horn, MD, Vanderbilt-Ingram Cancer Center Identifier:
First received: October 12, 2012
Last updated: June 28, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: September 2018 (Final data collection date for primary outcome measure)